Twinbeech Capital LP Zoetis Inc. Transaction History

Twinbeech Capital LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$165.67 - $199.94 $43.7 Million - $52.8 Million	264,043 New	264,043 $44.7 Million
Q2 2023 Aug 14, 2023	BUY	$160.94 - $186.23 $28.5 Million - $33 Million	177,224 Added 178.24%	276,656 $47.6 Million
Q1 2023 May 15, 2023	SELL	$145.48 - $175.02 $839,419 - $1.01 Million	-5,770 Reduced 5.48%	99,432 $16.5 Million
Q4 2022 Feb 14, 2023	BUY	$131.14 - $157.47 $13.8 Million - $16.6 Million	105,202 New	105,202 $15.4 Million
Q2 2022 Aug 15, 2022	SELL	$155.97 - $200.09 $11.6 Million - $14.9 Million	-74,524 Reduced 66.98%	36,743 $6.32 Million
Q1 2022 May 16, 2022	BUY	$181.39 - $234.03 $18.9 Million - $24.4 Million	104,384 Added 1516.55%	111,267 $21 Million
Q4 2021 Feb 14, 2022	BUY	$193.69 - $247.03 $932,036 - $1.19 Million	4,812 Added 232.35%	6,883 $1.68 Million
Q3 2021 Nov 15, 2021	BUY	$189.29 - $209.69 $392,019 - $434,267	2,071 New	2,071 $402,000

1,956

412M

1.02M

1.09M

Ticker ZTS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 468,139,008
Market Cap $82.8B
Description
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...

Get notified when there are updates to the investment portfolio of Twinbeech Capital LP, based on Form 13F filings with the SEC.

Stay updated on Twinbeech Capital LP with notifications on news.